[Reporter Ou Yuxiang/Taipei Report] The OTC Buying Center announces the remuneration information for the directors and supervisors of OTC companies.

There are 113 OTC companies with after-tax losses in 2021, but the total remuneration of directors and supervisors or the average remuneration of each director and supervisor has increased. The maximum remuneration for each director and supervisor is more than one million yuan.

According to the Public Information Observatory, SHIELD will have an after-tax loss of about 216 million yuan in 2021, but the average remuneration for each director and supervisor will reach 2.954 million yuan, the most among loss-making OTC companies, followed by Xisheng’s 1.317 million yuan It is the only loss-making company with more than one million yuan.

Compared with the previous year (2020), SHIELD's remuneration for directors and supervisors also increased the most, increasing by more than 2 million yuan.

Please read on...

Except for Shendun, Xisheng's after-tax loss in 2021 is about 165 million yuan, while the average remuneration for each director and supervisor is 1.317 million yuan, an increase of 326,000 yuan compared with the previous year, and the increase is also ranked fifth.

The third place is Xinjuke (3630)'s 943,000 yuan, an increase of 365,000 yuan, ranking fourth in the amount of increase.

Eslite Life (2926) ranked fourth in terms of average remuneration for directors and supervisors, with 779,000 yuan and Yuquan (6169) with 736,000 yuan, both of which increased compared with the previous year.

There are 15 loss-making companies with an average remuneration of more than 5 million yuan per director and supervisor.

In addition, among the 113 companies, Huahua Pharmaceutical (6446) has the highest loss of about 2.811 billion yuan, and its average remuneration per director and supervisor in 2021 will be 114,000 yuan.

However, in terms of the total remuneration of directors and supervisors, the total amount of Xisheng and Eslite Life decreased, the total amount of Aegis increased by 18.238 million, Xinjuke increased by 1.426 million, and Yuquan increased by 1.777 million.

In terms of companies listed on the OTC as a whole, the semiconductor factory Wenmao (3105) ranks first with an average remuneration of 14.35 million yuan per director in 2021; It is 10.31 million, ranking third and only 3 OTC companies with an average remuneration of more than 10 million per director.

In addition, the average remuneration of Xin Chuan (3264), a semiconductor factory, reached 9.96 million yuan.

IGX (3293) in the game industry, Hongyuan Securities (6015) and Fubon Securities (6026) in the financial industry also exceeded 8 million yuan.

Grasp the pulse of the economy with one hand I subscribe to Free Finance Youtube channel

Already added friends, thank you

Welcome to 【Free Finance】

feel good

Already liked it, thank you.

related news